Pear Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 200
Employees
  • Stock Symbol
  • PEAR
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $4.41
  • (As of Thursday Closing)

Pear Therapeutics General Information

Description

Pear Therapeutics Inc is engaged in developing and commercializing software-based medicines, called prescription digital therapeutics. It focuses to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Outcome Management (Healthcare)
Other Healthcare Services
Laboratory Services (Healthcare)
Hospitals/Inpatient Services
Managed Care
Stock Exchange
NAS
Primary Office
  • 200 State Street
  • 13th Floor
  • Boston, MA 02109
  • United States

Pear Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pear Therapeutics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.41 $4.31 $4.15 - $14.60 $608M 138M 726K -$1.03

Pear Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
Revenue 2,922 9,384 32,562
EBITDA (125,103) (94,030) (10,540)
Net Income (131,540) (97,023) (9,334)
Total Assets 87,513 132,366 109,692
Total Debt 26,820 26,345 15,163
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pear Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pear Therapeutics‘s full profile, request access.

Request a free trial

Pear Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Pear Therapeutics‘s full profile, request access.

Request a free trial

Pear Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pear Therapeutics Inc is engaged in developing and commercializing software-based medicines, called prescription digital
Other Healthcare Technology Systems
Boston, MA
200 As of 2021
00000
0.00 0000-00-00
000000000 00000

000000 0

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
00000000000 0000000
San Francisco, CA
00 As of 0000
0000
0000 0000-00-00
00000000000 0000

00000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
00000 0000000000 0000000000 0000000
San Francisco, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pear Therapeutics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mahana Therapeutics Venture Capital-Backed San Francisco, CA 00 0000 00000000000 0000
00000 Venture Capital-Backed San Francisco, CA 000 00000 000000 - 000 00000
00000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
000000000 Venture Capital-Backed Kirkland, WA 00 000.00 00000000000 000.00
0000000000000 Private Equity-Backed Boston, MA 0 000.00 000000000000 000.00
To view Pear Therapeutics’s complete competitors history, request access »

Pear Therapeutics Patents

Pear Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200372990-A1 Systems and methods for visualizing and modifying treatment of a patient utilizing a digital therapeutic Pending 22-May-2019 000000000
US-20200350076-A1 Systems and methods for clinical curation of crowdsourced data Pending 30-Apr-2019 000000000
US-20200330019-A1 Electronic devices and methods for treating depressive symptoms associated with multiple sclerosis Pending 17-Apr-2019 000000000
US-20200335191-A1 Electronic devices and methods for treatment of depressive symptoms, depressive disorders utilizing digital therapies Pending 17-Apr-2019 000000000
CA-3130620-A1 Systems and methods for the treatment of symptoms associated with migraines Pending 22-Feb-2019 A61B5/7275
To view Pear Therapeutics’s complete patent history, request access »

Pear Therapeutics Executive Team (17)

Name Title Board Seat Contact Info
Corey McCann Ph.D Chief Executive Officer, President & Board Member
Christopher Guiffre JD Chief Operating Officer & Chief Financial Officer
Kathy Jeffery Chief People Officer
Julia Strandberg Chief Commercial Officer
Erin Brenner Chief Product Development Officer
You’re viewing 5 of 17 executive team members. Get the full list »

Pear Therapeutics Board Members (19)

Name Representing Role Since
Alison Bauerlein Pear Therapeutics Board Member 000 0000
Andrew Schwab 5AM Ventures Board Member 000 0000
Ankita Jha Temasek Holdings Board Observer 000 0000
Corey McCann Ph.D Pear Therapeutics Chief Executive Officer, President & Board Member 000 0000
Dipchand Nishar Self Board Observer 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Pear Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pear Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pear Therapeutics‘s full profile, request access.

Request a free trial

Pear Therapeutics Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 16-Dec-2021 000000000 Other Healthcare Technology Systems 00000 000
0000000 00000 22-Jun-2021 0000000000 Special Purpose Acquisition Company (SPAC) 00000 000
Firsthand Technology (VR tech for pain treatment) 07-Jan-2020 Corporate Asset Purchase Buildings and Property 00000 000
To view Pear Therapeutics’s complete investments and acquisitions history, request access »